News Search Results
Apr 08, 2025, 12:31 ET Kemin Industries trauert um den Mitbegründer R.W. Nelson
den State of Iowa Economic Impact Award, 1991 den Ernst and Young Entrepreneur Achievement Iowa Award und 2004 den Iowa Biotechnology Association's Entrepreneur Achievement Biotechnology Award. Im Jahr 2006 wurde er in die Iowa Business Hall of Fame aufgenommen. R.W.
More news about: Kemin Industries
Apr 08, 2025, 12:27 ET A Kemin Industries lamenta a perda do cofundador R.W. Nelson
Iowa em 1987, o Prêmio Ernst and Young Entrepreneur Achievement Iowa em 1991 e o Prêmio de Biotecnologia de Empreendedorismo da Iowa Biotechnology Association em 2004. Ele foi introduzido no Iowa Business Hall of Fame em 2006. R.W. foi um líder servidor que construiu a Kemin com base
More news about: Kemin Industries
Apr 08, 2025, 12:01 ET CS Analytical Signs IT System Support Agreement with E-2 Consulting
cGMP, FDA-registered and inspected contract laboratory exclusively designed and dedicated to container and package testing for the pharmaceutical, biotechnology, and medical device industries, is excited to announce that it has partnered with E2 IT Consulting to support the CS Analytical IT environment.
More news about: CS Analytical
Apr 08, 2025, 11:18 ET Kemin Industries Mourns the Loss of Co-Founder R.W. Nelson
of Iowa Economic Impact Award in 1987, the Ernst and Young Entrepreneur Achievement Iowa Award in 1991, and the Iowa Biotechnology Association's Entrepreneur Achievement Biotechnology Award in 2004. He was inducted into the Iowa Business Hall of Fame in 2006. R.W. was a servant leader who built
More news about: Kemin Industries
Apr 08, 2025, 11:04 ET Kemin Industries Mourns the Loss of Co-Founder R.W. Nelson
of Iowa Economic Impact Award in 1987, the Ernst and Young Entrepreneur Achievement Iowa Award in 1991, and the Iowa Biotechnology Association's Entrepreneur Achievement Biotechnology Award in 2004. He was inducted into the Iowa Business Hall of Fame in 2006. R.W. was a servant leader who built
More news about: Kemin Industries
Apr 08, 2025, 10:30 ET US Digital Pathology Market worth US$2.01 billion by 2029 with 13.1% CAGR | MarketsandMarkets™
into pharmaceutical and biotechnology firms, hospital and reference labs, and research and academic institutes. In 2023, pharmaceutical and biotechnology firms accounted for the largest share among end users because of several significant reasons. Pharmaceutical and biotechnology companies rely heavily
More news about: MarketsandMarkets
Apr 08, 2025, 10:30 ET Alternative Protein Market to Reach $55.01 Billion by 2032, Growing at a CAGR of 14.3% from 2025--Exclusive Report by Meticulous Research®
consumption. The increasing adoption of plant-based, vegan, and flexitarian diets is fueling demand for protein-rich alternatives. Innovations in biotechnology and fermentation are enhancing the variety and functionality of alternative proteins, making them more appealing to consumers and food manufacturers.
More news about: Meticulous Market Research Pvt. Ltd.
Apr 08, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers - SANA
April 8, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA) and certain officers. The class action, filed in the United States
More news about: Pomerantz LLP
Apr 08, 2025, 10:00 ET Care Fertility and U-Ploid Biotechnologies Announce Research Collaboration to Improve Egg Quality in Women of Advanced Maternal Age
www.carefertility.com. About U-Ploid Biotechnologies: U-Ploid is a biotechnology company developing first-in-class reproductive health therapeutics to address the global unmet need of age-related fertility decline. The Company's
More news about: U-Ploid Biotechnologies
Apr 08, 2025, 09:40 ET GenScript Biotech Releases 2024 ESG Report, Highlighting Sustainability Practices and Progress
high-potential talent pool to fuel long-term growth. Giving Back to Communities: Advancing Social Responsibility Through Biotechnology: GenScript supports various causes that align with its values and mission, focusing on health, education, and environmental sustainability.
More news about: GenScript Biotech Corporation
Apr 08, 2025, 09:31 ET Amity University Rajasthan Students Shine at Times Fashion Week
Universities Rankings 2025. The University provides students with cutting-edge laboratories for languages, media studies, education, pharmacy, biotechnology, engineering, hotel management, business management, and scientific research, as well as sophisticated facilities for a variety of research projects.
More news about: Amity University Rajasthan
Apr 08, 2025, 09:00 ET BIOTECHBEAUTY LAUNCHES A MICROBIOME-FRIENDLY MAKEUP LINE, BRIDGING BIOTECH-POWERED SKINCARE & HIGH-PERFORMANCE COLOR
BiotechBeauty introduces its revolutionary microbiome-friendly makeup line, seamlessly blending cutting-edge biotechnology with high-performance color. Founded by cosmetic chemist Alanna Tran, this clinically backed brand is redefining
More news about: BiotechBeauty
Apr 08, 2025, 09:00 ET Amacathera Collaborates With Leading Global Pharmaceutical Company To Develop Single-Injection, Long-Acting Biologic Using Its Advanced Hydrogel Delivery Platform, Amacagel™
TORONTO, April 8, 2025 /PRNewswire/ - AmacaThera, a clinical-stage biotechnology company specializing in drug delivery, announced a new pipeline program in collaboration with a leading global pharmaceutical company. Through this
More news about: AmacaThera Inc.
Apr 08, 2025, 09:00 ET Amacathera Collaborates With Leading Global Pharmaceutical Company To Develop Single-Injection, Long-Acting Biologic Using Its Advanced Hydrogel Delivery Platform, Amacagel™
TORONTO, April 8, 2025 /PRNewswire/ -- AmacaThera, a clinical-stage biotechnology company specializing in drug delivery, announced a new pipeline program in collaboration with a leading global pharmaceutical company. Through this
More news about: AmacaThera Inc.
Apr 08, 2025, 08:00 ET ArtBlood Signs MOU with Expression Manufacturing for Large-Scale In Vitro Red Blood Cell Production
ATLANTA, April 8, 2025 /PRNewswire/ -- ArtBlood, a biotechnology company specializing in transfusion blood production, announced that it has signed a Memorandum of Understanding (MOU) with Expression Manufacturing
More news about: Expression Therapeutics, Inc.
Apr 08, 2025, 08:00 ET Freenome Names Aaron Elliott, Ph.D., as Chief Executive Officer to Lead the Company's Next Chapter of Commercial Growth and Product Innovation
BRISBANE, Calif., April 8, 2025 /PRNewswire/ -- Freenome, a biotechnology company pioneering an early cancer detection platform, today announced the appointment of Aaron Elliott, Ph.D., as
More news about: Freenome Holdings, Inc.
Apr 08, 2025, 05:45 ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. Lawsuit - SANA
April 8, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Sana Biotechnology, Inc. ("Sana Biotechnology, Inc." or the "Company") (NASDAQ: SANA) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
Apr 08, 2025, 05:45 ET Shareholders that lost money on ICON Public Limited Company(ICLR) should contact Levi & Korsinsky about pending Class Action - ICLR
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Levi & Korsinsky, LLP
Apr 08, 2025, 01:00 ET Synthego and Vita Therapeutics Announce Strategic Licensing Agreement for hfCas12Max CRISPR Nuclease
high-fidelity nuclease portfolio, delivering new opportunities for therapeutic advancement. About SynthegoSynthego is a leader in biotechnology, dedicated to delivering best-in-class CRISPR solutions with a mission to accelerate research and development in the pursuit of improved human health.
More news about: Synthego
Apr 08, 2025, 00:01 ET National Security Commission on Emerging Biotechnology Urges Swift Action to Protect U.S. National Security
finds that emerging biotechnology is rapidly advancing, and the impact of biotechnology innovation already extends far beyond health, touching industries from agriculture and infrastructure, to manufacturing and defense. The intersection of artificial intelligence (AI) and biotechnology is accelerating this
More news about: National Security Commission on Emerging Biotechnology
Apr 07, 2025, 17:14 ET NeuroSense Therapeutics Reports Year End 2024 Financial Results and Provides Business Updates
April 7, 2025 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a clinical-stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today reports its financial results for the year ended December
More news about: NeuroSense
Apr 07, 2025, 16:05 ET INVESTOR DEADLINE THIS WEEK: ICON PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
insufficient to shield ICON from the adverse effects of a significant market downturn; (iii) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Robbins Geller Rudman & Dowd LLP
Apr 07, 2025, 16:01 ET Innocan Pharma Broadens Intellectual Property Coverage for its Liposomal CBD Injection Across Asia and Announces Private Placement of Units
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that a divisional application for its Chinese (CN) liposome-based CBD technology patent was filed.
More news about: Innocan Pharma Corporation
Apr 07, 2025, 16:01 ET Innocan Pharma Broadens Intellectual Property Coverage for its Liposomal CBD Injection Across Asia and Announces Private Placement of Units
2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that a divisional application for its Chinese (CN) liposome-based CBD technology patent was filed.
More news about: Innocan Pharma Corporation
Apr 07, 2025, 14:14 ET NC Community Colleges Shine in Statewide Celebration of Excellence
amazing faculty and staff." The Excellence in Teaching Award to Dr. Lisa Smelser, Biotechnology Chair at Central Carolina Community College, presented by the
More news about: North Carolina Community College System